Top compounds associated with response to NR2E3


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CCLE pan-cancer AAC -0.075 0.08
mRNA lapatinib CCLE pan-cancer AAC 0.078 0.08
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.08
mRNA itraconazole CTRPv2 pan-cancer AAC -0.066 0.08
mRNA paclitaxel GDSC1000 pan-cancer AAC -0.086 0.08
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.077 0.09
mRNA UNC1215 GDSC1000 pan-cancer AAC -0.058 0.09
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.069 0.09
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.06 0.09
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.09
Download CSV